檢索結果 - Brendan C. Bender

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer

    A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer 由 Brendan C. Bender, Douglas D. Leipold, Keyang Xu, Ben‐Quan Shen, Jay Tibbitts, Lena E. Friberg

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Clinical Pharmacology of Cytokine Release Syndrome with T-cell Engaging Bispecific Antibodies: Current Insights and Drug Development Strategies

    Clinical Pharmacology of Cytokine Release Syndrome with T-cell Engaging Bispecific Antibodies: Current Insights and Drug Development Strategies 由 Kendra K. Radtke, Brendan C. Bender, Zao Li, David C. Turner, Sumedha Roy, Anton Belousov, Chi‐Chung Li

    出版 2024
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma

    Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma 由 Brendan C. Bender, Chi‐Chung Li, Mathilde Marchand, David C. Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Y. Jin, Chunze Li, Shen Yin, Michael C. Wei, Pascal Chanu

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: